Intravenous Immunoglobulin Therapy (IVIG) is used to help treat immune system disorders. It is infused intermittently every 3-8 weeks depending on the disease state and response to therapy.

• IV access required
• Administered utilizing an infusion pump
• Home health nurse will visit patient to ensure IV access as well as monitor patient throughout the infusion. RN will adjust the rate based on patient response to infusion.
• No first dosing at home

 

 

Indications/Candidates for Intravenous Immunoglobulin Therapy

• CVID (Common Variable Immunodeficiency)
• Chronic Inflammatory demyelinating polyneuropathy (CIDP)
• Primary immunodeficiency disorders

Subcutaneous Immunoglobulin Therapy (ScIG) is an Immunoglobulin that is administered under the skin. It is administered intermittently every 1-4 weeks depending on the medication and MD orders.

• No IV access required
• Multiple access sites may be required
• Administered using an infusion pump
• Home Health nurse is required for initial teaching, after which patient can self-infuse.
• Local site reactions can be expected.
• No first dosing at home if Nieve to IG therapy.

 

 

Indications/Candidates for Subcutaneous Immunoglobulin Therapy (ScIG)

• Primary humoral immunodeficiency (PI) in adults
• Hizentra and Gammagard can be utilized in patients 2 years of age or older.